Abstract
Glucagon and catecholamines share numerous metabolic effects. In addition, catecholamines are potent stimulators of glucagon secretion and, under certain conditions, glucagon stimulates catecholamine release from the adrenal medulla. Finally, the involvement of catecholamines has been invoked to explain some of the metabolic actions of glucagon. The stimulation of glucagon release by catecholamines has been reviewed in detail in Chap. 30 while the possible involvement of catecholamines in some effects of glucagon has been considered in Chaps. 37 and 38. In this short contribution, we will summarize the in vitro and in vivo studies dealing with the effects of glucagon on catecholamine release and review the potential of these findings for the diagnosis of pheochromocytoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beggs I (1978) Pheochromocytoma diagnosed during barium meal. Br J Radiol 51: 918
Bernheim C, Jaillon P, Graisely B, Cloarec M, Debray J, Cheymol G (1978) Diagnostic d’un pheochromocytome par dosage des catecholamines plasmatiques au cours du test au glucagon. Nouv Presse Med 7: 553–555
Cession-Fossion A, Lecomte J, Lefebvre P (1966) Sur la stimulation medullo surrenalienne induite chez le rat par le glucagon. CR Soc Biol (Paris) 160: 723–726
Cremer GM, Molnar GD, Moxness KE, Sheps SG, Maher FT, Jones JD (1968) Hormonal and biochemical response to glucagon administration in patients with pheochromocytoma and in control subjects. Mayo Clin Proc 43: 161–176
Dexter RN, Allen DO (1970) A glucagon–sensitive adenylcyclase system in pheochromocytoma. Clin Res 18: 601
Galloway JA (1972) The pharmacology and clinical use of glucagon. In: Lefebvre PJ, Unger RH (eds) Glucagon: molecular physiology, clinical and therapeutic implications. Pergamon, Oxford, p 299
Geelhoed GW (1980) CAT scans and catecholamines. Surgery 87: 719–720
Hinterberger H, Wilcken DEL (1974) The effect of prolonged glucagon infusions on the urinary excretion of catecholamines and 3-hydroxy-3-methoxymandelic acid and on adrenal medullary tissue levels of catecholamines in patients with severe cardiac disease. Clin Chim Acta 52: 153–161
Kitabchi AE, Solomon SS, Williams RH (1968) Stimulatory effect of insulin and glucagon on phenylethanolamine-TV-methyl transferase of rat adrenal. Proc Soc Exp Biol Med 127: 296–300
Kuchel O, Hamet P, Bun NT, Larochelle P (1981) Basis of falsepositive glucagon tests for pheochromocytoma. Clin Pharmacol Ther 29: 687–694
Kuschke H J, Klusmann H, Schölkens B (1966 a) Über die Wirkung von Glucagon auf den Katecholamin-Plasmaspiegel beim Menschen. Arch Exp Pathol Pharmakol 253: 65
Kuschke HJ, Klusmann N, Schölkens B (1966 b) Untersuchungen über die Wirkung von Glukagon auf des sympatho-adrenale System des Menschen. Klin Wochenschr 44: 1297–1300
Lawrence AM (1965) A new provocative test for pheochromocytoma. Ann Intern Med 63: 905–906
Lawrence AM (1967) Glucagon provocative test for pheochromocytoma. Ann Intern Med 66: 1091–1096
Lawrence AM, Forland M (1964) Glucagon provocative test for pheochromocytoma. J Lab Clin Med 64: 878
Lefèbvre P, Dresse A (1961) Influence du glucagon sur le taux des catécholamines surréna liennes chez le rat. CR Soc Biol (Paris) 155: 412–414
Lefèbvre PJ, Cession-Fossion A, Luyckx AS (1966) Glucagon test for pheochromocytoma. Lancet 2: 1366
Lefèbvre PJ, Cession-Fossion A, Luyckx AS, Lecomte J, Van Cauwenberge H (1968) Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn 172: 393–404
Levey GS, Weiss SR, Ruiz E (1975) Characterization of the glucagon receptor in a pheochromocytoma. J Clin Endocrinol Metab 40: 720–723
Llorens I, Borrell J, Borrell S (1973) Effects of insulin, glucagon and adrenocorticotrophin on the levels of corticosteroids, noradrenaline, adrenaline and ascorbic acid in the adrenal glands of cat. Horm Res 4: 321–330
Lupulescu A, Chivu V, Petrovici A (1966) Effect of aldosterone, glucagon and growth hormone on the catecholamine content and the evolution of chromaffin hyperplasia in guinea pigs. Experientia 22: 222–223
Mandai T, Ogihara T, Hata T, Okada Y, Ogasahara S, Mikami H, Nakamaru M, Kumahara Y (1980) Urinary catecholamine response to glucagon in young and elderly patients with essential hypertension. J Am Geriatr Soc 28: 462–465
McLoughlin M, Langer B, Wilson DR (1981) Lifethreatening reaction to glucagon in a patient with pheochromocytoma. Radiology 140: 841–842
Roth RH, Stjarne L, Levine RJ, Giarman NJ (1968) Abnormal regulation of catecholamines synthesis in pheochromocytoma. J Lab Clin Med 72: 397–403
Sarcione EJ, Back N, Sokal JE, Mehlman B, Knoblock E (1963) Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology 72: 523–526
Scian LF, Westermann CD, Verdesca AS, Hilton JG (1960) Adrenocortical and medullary effects of glucagon, Am J Physiol 199: 867–870
Schoor I, Hinshaw HT, Cooper MA, Mahaffee D, Ney RL (1972) Adenylcyclase hormone responses of certain human endocrine tumors. J Clin Endocrinol Metab 34: 447–451
Sebel EF, Hull RD, Kleerekoper M, Stokes GS (1974) Response to glucagon in hypertensive patients with and without pheochromocytoma. Am J Med Sci 267: 337–343
Sheps SG, Maher FT (1968) Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA 205: 895–899
Simard S J (1974) Valeur diagnostique des catécholamines plasmatiques dans le test au glucagon pour le phéochromocytome. Union Med Can 103: 460–465
Siqueira-Filho AG, Sheps SG, Maher FT, Nai Siang J, Elveback LR (1975) Glucagon blood catecholamine test. Arch Intern Med 135: 1227–1231
Uda M, Sakamoto N, Tsuchiya M, Ito K, Ikeda M, Matsukura S, Fujita T (1982) Responses of plasma catecholamine and plasma renin activity after glucagon stimulation in essential hypertension. Acta Endocr 101: 242–247
Wahlen Ch, Appeltants A, Limet R (1983) Neurofibromatose et phéochromocytome.Histoire d’un cas. Rev. Med. Liege 38: 56–57
Young JB, Candsberg L, Knopp RH (1976) Effect of intravenous glucagon on urinary catecholamine excretion in normal man. Metabolism 25: 233–237
Zicha L, Schmid E, Weist F, Winkler E (1965) Der Einfluß von Glukagon, Insulin, Adrenalin und Sulfonylharnstoffen auf Blutzucker und Vanillinmandelsäure im Harn bei gesunden Kontrollpersonen, Leberkranken und anderen Patienten mit Dysproteinämie. Verh Deutsch Ges Inn Med 71: 499–501
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lefebvre, P.J., Luyckx, A.S. (1983). Glucagon and Catecholamines. In: Lefebvre, P.J. (eds) Glucagon II. Handbook of Experimental Pharmacology, vol 66 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69019-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-69019-8_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69021-1
Online ISBN: 978-3-642-69019-8
eBook Packages: Springer Book Archive